LGD-4033 Description:
LGD-4033 / Ligandrol
Synonyms:4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile
CAS:1165910-22-4
MF:C14H12F6N2O
MW:338.2482992
Usage:LGD-4033 (Ligandrol) is a selective oral androgen receptor modulator (SARM) that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It is in a class of androgen receptor (AR) ligands that are tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss.
LGD-4033 COA:
| Product | LGD-4033 | CAS No. | 1165910-22-4 |
| Quantity | 2KG | Man.date | 2016-09-18 |
| Test standard | In-house standard | Expiry date | 2 years |
| Items | Specifications | Results |
| Appearance | White crystalline powder | Conforms |
| HNMR | H group on the peak of the correct attribution | Conforms |
| Loss on Drying | ≤0.5% | 0.3% |
| Heavy Metals | Not more than 10ppm | Conforms |
| Assay(HPLC) | ≥98% | 99.2% |
| Conclusion: The product meets In-house specifications. |
LGD-4033 Usage:
LGD-4033 is a selective androgen receptor modulator a novel non-steroidal, oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity, class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.
| Product Name | CAS NO. |
| MK-2866 (Ostarine, Enobosarm) | 401900-40-1 |
| GW501516 (Cardarine) | 317318-70-0 |
| LGD-4033 (Ligandrol) | 1165910-22-4 |
| RAD-140 (Testolone) | 1182367-47-0 |
| MK-677 (Ibutamoren) | 159752-10-0 |
| YK11 | 431579-34-9 |
| Andarine (S-4) | 401900-40-1 |
| SR9009 (Stenabolic) | 1379686-30-2 |
| Aicar | 2627-69-2 |
China
